AOP Orphan Pharmaceuticals Reports Positive Phase II Data of Novel Mono-Pegylated Interferon Alpha 2b for Treatment of Polycythemia Vera (PV)
. - AOP Orphan announces results from phase II trial in PV at ASH Annual Meeting in Atlanta, U.S.A. - Promising effic…